INTRODUCTION Inverse psoriasis is a rare form of psoriasis that affects between 3% and 7% of the patients with psoriasis. It can comprise genital skin folds as part of genital psoriasis, and it is one of the most commonly seen dermatoses of this area. There are few evidence-based studies about the treatment of intertriginous psoriasis involving genital skin folds. CASE PRESENTATION The author...

OBJECTIVES The balance of service provision for people with psoriasis across community and hospital sectors is inappropriate in many localities. Disease-specific models are being used by policy makers to inform public health decision making and guide their long-term budgets. The aim of the present study was to develop an interactive psoriasis model to compare the 2-year outcomes of topical trea...

EKV: erythrokeratoderma variabilis PSEK: progressive symmetrical erythrokeratoderma INTRODUCTION Erythrokeratodermas are rare genodermatoses that are characterized by well-defined erythematous, hyperkeratotic plaques. They are categorized into 2 main types: progressive symmetrical erythrokeratoderma (PSEK) and erythrokeratoderma variabilis (EKV). Because their histologic findings are very simil...

In this article, we share the raw cytokine data obtained from basal and stimulated synovial stromal cells cultured from patients with rheumatoid arthritis or osteoarthritis. This data article is related to the research article entitled "1,25D3 and calcipotriol, its hypocalcemic analog, exert a long-lasting anti-inflammatory and anti-proliferative effect in synoviocytes cultured from patients wi...

Background: Cutaneous immune-related adverse event (irAE) is one of the common side effects in cancer patients receiving immune checkpoint inhibitors. Exacerbation psoriasis, and new-onset de novo psoriasis have been reported after use inhibitors (ICI). The detailed pathomechanism therapeutic still unclear. Methods: We enrolled suffering from irAE with exacerbation during 2018-2022 Chang Gung M...

Interleukin (IL)-31 is a key cytokine that contributes to pruritus in atopic dermatitis (AD). Recently, the treatment with anti-IL-31 receptor alpha (RA) antibody exhibited remarkable antipruritic effect AD patients. In clinical trial, serum levels of thymus activation-regulated chemokine (TARC), biomarker AD, were unexpectedly increased some patients treated anti-IL-31RA antibodies, without an...